Study of an investigational injection for weight management in healthy or overweight adults
Part of Hormones & metabolism clinical trials.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must be either at a healthy weight (BMI 19–28) or overweight (BMI 28–40) – there are two groups in this study.
- You must be willing to avoid alcohol, smoking, and caffeinated drinks (like coffee, tea, and cola) for about two days before each dose and while you stay at the study site.
- Your weight should be fairly stable – no more than a 5% change in the last 3 months.
- You must agree to use reliable birth control and not donate sperm or eggs for 4 months after the last dose.
- You must not have diabetes, a history of pancreatitis, or certain stomach or intestinal conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
This trial tests a new injection, HEC-007, to see if it is safe in healthy adults and in people who are overweight or obese. It may help with weight management and related health issues.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.